Skip to main content

Advertisement

Table 2 Demographic and clinical characteristics of the study cohort

From: Sex differences in the morphological failure patterns following hip resurfacing arthroplasty

   entire study cohort entire study cohort n = 204 valid data on sex n = 173
    unknown sex n = 31 valid data on sex n = 173 men n = 88 women n = 85
age (median age [years], IQR) 56, 50 to 60 51, 48 to 60 56, 50 to 60 56, 51 to 60 56, 49 to 60
    P = 0.531 P = 0.584
clinical diagnosis osteoarthritis 107 5 102 54 48
  avascular necrosis of femoral head 10 0 10 8 2
  rheumatoid arthritis 7 0 7 3 4
  arthritis secondary to trauma 7 0 7 3 4
  developmental hip dysplasia 17 1 16 6 10
    P = 0.867 P = 0.288
THRA design ASR™ 143 18 125 66 59
  DUROM® 16 1 15 8 7
  Cormet™ 20 6 14 6 8
  BHR™ 14 4 10 4 6
  ReCAP® 11 2 9 4 5
    P = 0.127 P = 0.877
duration of implantation (median in situ time [days], IQR) 147, 51 to 399 127, 25 to 570 147, 55 to 384 124, 54 to 327 182, 55 to 445
    P = 0.724 P = 0.373
size of the femoral component (median diameter [mm], IQR) 46, 44 to 50 46, 44 to 50 46, 42 to 48 50, 48 to 52 44, 42 to 46
    P = 0.175 P = 0.000